---

---

corporation   symbols : Lly   

save search

---

Innovent Dosed First Participant in Phase 3 Clinical Study (Neoshot) of IBI310 (Anti-CTLA-4 Monoclonal Antibody) in Combination with Sintilimab for MSI-H/dMMR Colon Cancer Neoadjuvant Therapy
Published: 2024-03-27 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -7.26% | O: -0.26% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -6.27% | O: 0.49% H: 0.84% C: -0.07%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -5.89% | O: 1.06% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -7.43% | O: -0.09% H: 1.42% C: 1.1%
ibi310 first cancer colon therapy study

---

Merus Announces Financial Results for the Fourth Quarter and Full Year 2023 and Provides Business Update
Published: 2024-02-28 (Crawled : 21:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -4.14% | O: -0.6% H: 0.45% C: 0.08%
MRUS | $39.83 -1.58% -1.61% 800K |

Health Technology

| -18.25% | O: 2.3% H: 0.58% C: -2.69%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -12.72% | O: 0.38% H: 0.0% C: -3.07%
business year update financial results

---

Aclaris Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides a Corporate Update
Published: 2024-02-27 (Crawled : 12:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -5.91% | O: -2.2% H: 2.39% C: 1.34%
ACRS | $1.25 1.63% 1.6% 580K |

Health Technology

| 2.48% | O: 2.48% H: 10.48% C: -3.23%
year update therapeutics financial results

---

Neuroblastoma Drugs Market to Reach $1.3 Billion, Globally, by 2032 at 6.2% CAGR: Allied Market Research
Published: 2024-02-26 (Crawled : 15:00) - prnewswire.com
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 5.46% | O: 3.06% H: 0.0% C: -2.34%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -5.62% | O: 0.23% H: 1.16% C: 0.08%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -5.28% | O: -0.19% H: 0.23% C: -2.02%
UTHR | $237.99 0.45% 0.45% 400K |

Health Technology

| 4.8% | O: -0.48% H: 1.17% C: -1.04%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 4.13% | O: 0.38% H: 0.44% C: -0.23%
reach research market

---

United Therapeutics Corporation Reports Fourth Quarter and Full Year 2023 Financial Results
Published: 2024-02-21 (Crawled : 12:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -3.88% | O: -2.33% H: 1.55% C: 1.06%
UTHR | $237.99 0.45% 0.45% 400K |

Health Technology

| 11.1% | O: 2.59% H: 3.66% C: -0.24%
year corporation therapeutics financial results

---

Animal Therapeutics and Diagnostics Global Market Report 2024 - Dermatological Disease Management in Animals to Propel Market Growth
Published: 2024-02-13 (Crawled : 23:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -0.29% | O: -2.71% H: 0.0% C: 0.0%
ZTS | News | $146.5 -4.32% 0.0% 6.2M |

Health Technology

| -20.16% | O: 0.93% H: 0.7% C: -0.6%
TMO | News | $544.78 0.6% 0.0% 1.7M |

Health Technology

| 1.15% | O: 0.56% H: 1.3% C: 1.22%
QGEN | $40.0 1.34% 0.0% 1.1M |

Health Technology

| -6.67% | O: -1.14% H: 1.3% C: 1.2%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -2.24% | O: 0.38% H: 2.44% C: 1.54%
ELAN | $12.95 -4.57% 0.0% 5.7M |

Process Industries

| -17.46% | O: 1.53% H: 1.16% C: 0.82%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 0.28% | O: -1.1% H: 0.0% C: 0.0%
QGEN | $40.0 1.34% 0.0% 1.1M |

Health Technology

| -6.67% | O: -1.14% H: 1.3% C: 1.2%
PAHC | $13.31 2.07% 2.03% 130K |

Health Technology

| 17.39% | O: 1.32% H: 4.7% C: 4.09%
NEOG P | $11.6 -2.77% -2.84% 1.9M |

Health Technology

| -29.38% | O: -0.24% H: 4.39% C: 3.29%
management propel disease report animal global animals dermatological diagnostics therapeutics growth market

---

Checkpoint Inhibitors Market Forecast Reveals Impressive Growth With Focus on Novel Therapies and Regional Expansion
Published: 2024-02-12 (Crawled : 23:00) - prnewswire.com
GLAXF | News | $20.2 -14.18% 510 |

Health Technology

| -1.6% | O: 3.52% H: 0.0% C: -1.18%
AZNCF | News | $138.24 -4.19% 800 |

Health Technology

| 12.87% | O: 0.06% H: 2.34% C: 2.29%
ALPMY | $9.47 -1.11% 520K |

Manufacturing

| -12.2% | O: 0.37% H: 0.74% C: 0.28%
TAK | News | $13.24 0.61% 0.0% 1.3M |

Health Technology

| -7.48% | O: 0.14% H: 0.35% C: 0.07%
NVS | $94.36 1.93% 0.0% 2.3M |

Health Technology

| -6.14% | O: -0.34% H: 0.23% C: -1.13%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -5.55% | O: 0.7% H: 0.0% C: 0.0%
GSK | News | $39.75 1.22% 0.0% 1.6M |

Health Technology

| -3.21% | O: 1.22% H: 0.07% C: -0.43%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| -1.49% | O: -0.96% H: 1.75% C: 1.75%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -1.65% | O: -0.18% H: 0.48% C: -1.91%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| -3.85% | O: 0.8% H: 0.0% C: 0.0%
ZLAB | $14.08 -0.99% -0.99% 470K |

Health Technology

| -22.73% | O: -1.15% H: 1.03% C: -1.5%
VRTX | News | $394.43 0.24% 0.24% 1.3M |

Health Technology

| -5.79% | O: -0.28% H: 0.49% C: -0.32%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| 0.22% | O: -0.06% H: 0.0% C: 0.0%
IPHA | $2.48 5.53% 5.24% 9.4K |

Health Technology

| -5.43% | O: -3.1% H: 1.2% C: -0.8%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -9.49% | O: 3.8% H: 1.1% C: -1.17%
BIIB | $194.39 2.03% 1.99% 1.6M |

Health Technology

| -20.58% | O: -3.72% H: 0.58% C: -3.82%
AZN | News | $68.56 0.29% 0.29% 4.7M |

Health Technology

| 11.63% | O: -0.26% H: 0.73% C: -0.36%
ARGX | $360.11 0.47% 0.47% 330K |

Health Technology

| -8.27% | O: -2.3% H: 1.65% C: 0.83%
AMGN | $269.03 2.39% 2.33% 3.4M |

Health Technology

| -8.66% | O: 0.06% H: 0.31% C: -1.4%
expansion growth market

---

Veterinary Dermatology Drugs Market Set to Surge with Strong CAGR by 2024, Insights on Emerging Trends
Published: 2024-02-08 (Crawled : 04:00) - prnewswire.com
ZTS | News | $146.5 -4.32% 0.0% 6.2M |

Health Technology

| -25.67% | O: -0.51% H: 0.47% C: -0.17%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 0.13% | O: 0.41% H: 1.74% C: 1.01%
veterinary trends set market

---

Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
Published: 2024-02-07 (Crawled : 09:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 3.02% | O: 0.76% H: 4.31% C: 2.11%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -0.49% | O: 1.33% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -12.21% | O: -0.65% H: 0.57% C: -3.21%
first management drug application china

---

Proniras Corporation Secures New Series B Financing and Names New Board Members to Support Phase 1 Study of Novel Treatment for Opiate Withdrawal
Published: 2024-02-01 (Crawled : 22:00) - biospace.com/
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 12.5% | O: 0.27% H: 2.04% C: 2.02%
corporation series treatment study

---

Drug-Eluting Balloons Global Market is Expected to Expand at a Healthy Growth Rate of ~8% by 2028, Predicts DelveInsight
Published: 2024-01-24 (Crawled : 22:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K |

Health Technology

| -49.99% | O: 3.54% H: 0.0% C: 0.0%
TRUMY | $16.507 0.79% 34K |

Manufacturing

| -51.43% | O: -0.3% H: 0.18% C: -0.06%
PHG | $19.98 0.0% 540K |

Health Technology

| -12.52% | O: 0.0% H: 0.57% C: 0.48%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 14.61% | O: -1.0% H: 0.84% C: 0.04%
BSX | $67.33 -0.13% -0.31% 7M |

Health Technology

| 12.37% | O: 0.58% H: 0.98% C: 0.93%
SRDX | News | $26.47 0.3% 0.3% 55K |

Health Technology

| -23.88% | O: 1.03% H: 0.0% C: -1.34%
expected global growth market

---

Implantable Drug Delivery Devices Global Market to Exhibit Growth at a Considerable CAGR of ~6% by 2028, Assesses DelveInsight
Published: 2024-01-23 (Crawled : 23:00) - prnewswire.com
TRUMF | $16.928 -17.59% 1.9K |

Health Technology

| -52.51% | O: -4.99% H: 0.0% C: -0.06%
TRUMY | $16.507 0.79% 34K |

Manufacturing

| -52.49% | O: -1.36% H: 0.0% C: -0.82%
WST | $372.04 -1.4% 0.0% 440K |

Health Technology

| 5.8% | O: 0.67% H: 0.46% C: -1.49%
TFX | $206.56 -0.4% 0.0% 420K |

Health Technology

| -16.68% | O: 0.18% H: 0.52% C: -2.57%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -7.65% | O: -0.32% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 15.35% | O: 0.61% H: 1.52% C: 0.03%
BMY | $48.93 1.3% 0.0% 10M |

Health Technology

| -2.37% | O: 0.16% H: 0.84% C: 0.08%
BSX | $67.33 -0.13% -0.31% 7M |

Health Technology

| 11.07% | O: -0.18% H: 0.5% C: -0.98%
ABBV | $166.41 1.06% 0.0% 5.5M |

Health Technology

| 1.0% | O: 1.44% H: 0.0% C: 0.0%
PODD | $166.255 0.93% 0.92% 840K |

Health Technology

| -18.62% | O: 0.07% H: 1.08% C: -1.59%
drug global growth market

---

CAR T-Cell Therapy Market to Register Stunning Growth During the Study Period (2019-2032) | DelveInsight
Published: 2024-01-23 (Crawled : 22:00) - prnewswire.com
ACLX | $51.67 -5.19% -5.48% 740K |

| -7.9% | O: 1.59% H: 1.14% C: -1.42%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 15.35% | O: 0.61% H: 1.52% C: 0.03%
PSTX | $2.02 1.0% 0.99% 640K |

Health Technology

| -36.68% | O: 1.57% H: 4.94% C: 1.54%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -15.39% | O: 0.29% H: 0.15% C: -1.95%
BEAM | $23.9 -1.69% -1.72% 4.5M |

Health Technology

| -4.4% | O: 1.88% H: 0.88% C: -2.79%
t-cell therapy growth study market

---

Rehabilitation Equipment Global Market to Showcase Growth at a CAGR of ~5% by 2028, Examines DelveInsight
Published: 2024-01-22 (Crawled : 23:00) - prnewswire.com
NVRO | $12.07 -2.03% 0.0% 390K |

Health Technology

| -36.51% | O: 2.42% H: 0.0% C: -3.75%
MDT | $79.48 0.37% -0.29% 6.7M |

Health Technology

| -8.08% | O: 0.45% H: 0.58% C: -0.6%
JNJ | News | $147.91 1.49% -0.03% 9.6M |

Health Technology

| -8.67% | O: -1.11% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 15.13% | O: -0.51% H: 0.37% C: 0.32%
BSX | $67.33 -0.13% -0.31% 7M |

Health Technology

| 10.85% | O: 0.1% H: 0.25% C: -0.3%
ABT | News | $107.28 1.91% 0.18% 10M |

Health Technology

| -6.66% | O: -0.07% H: 0.0% C: 0.0%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -9.45% | O: -2.05% H: 0.0% C: 0.0%
DYNT | $0.52 -6.53% -6.98% 210K |

Health Technology

| 5.28% | O: -1.65% H: 0.0% C: -1.03%
ATEC | $12.54 1.62% 1.59% 1.3M |

Health Technology

| -21.18% | O: 1.07% H: 0.0% C: -0.5%
global growth market

---

AAV Vectors in Gene Therapy Market is Predicted to Observe Skyrocketed Growth During the Study Period (2019-2032) | DelveInsight `
Published: 2024-01-16 (Crawled : 22:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -10.78% | O: -1.83% H: 0.0% C: 0.0%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 14.46% | O: 0.77% H: 0.17% C: -1.65%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -10.39% | O: 0.45% H: 0.06% C: -0.5%
RGNX | $15.67 -2.73% -2.87% 570K |

Health Technology

| 2.75% | O: -0.13% H: 0.0% C: -7.15%
ADVM | $11.34 1.7% 1.68% 140K |

Health Technology

| 1305.2% | O: -0.69% H: 2.32% C: -0.12%
therapy growth study market

---

Innovent Announces the First Phase 3 Clinical Trial of Mazdutide in Chinese Adults with Overweight or Obesity Met the Primary and All Key Secondary Endpoints, and Plans to Submit NDA of Mazdutide to the NMPA
Published: 2024-01-09 (Crawled : 00:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 16.02% | O: 0.65% H: 0.69% C: -0.73%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -10.15% | O: 0.74% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -20.46% | O: 0.0% H: 0.53% C: -2.19%
obesity first chinese key trial

---

Mesa Laboratories Appoints Mark Capone to its Board of Directors
Published: 2024-01-08 (Crawled : 13:00) - globenewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 17.42% | O: 0.63% H: 0.58% C: 0.58%
DHR | $235.51 -0.36% 0.0% 2.3M |

Health Technology

| 2.3% | O: -0.56% H: 2.71% C: 2.6%
MLAB | $101.19 1.58% 1.55% 27K |

Health Technology

| 1.83% | O: -0.03% H: 3.71% C: 3.69%

---

Innovent Dosed First Participant in Phase 3 Clinical Study (GLORY-2) of Mazdutide (IBI362) Higher Dose 9 mg in Chinese Adults with Obesity
Published: 2024-01-02 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -6.94% | O: -0.02% H: 0.41% C: 0.41%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 24.6% | O: -0.43% H: 2.12% C: 2.03%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.66% | O: -0.45% H: 0.0% C: 0.0%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -16.63% | O: -0.64% H: 4.97% C: 4.9%
ibi362 obesity first chinese study

---

Innovent and Xuanzhu Enter into Clinical Trial Collaboration Investigating Combination Therapy of Sintilimab (PD-1 inhibitor) and A Novel ADC Candidate for Advanced Solid Tumors in China
Published: 2023-12-28 (Crawled : 00:00) - prnewswire.com
SNYNF | News | $92.7 -2.18% 600K |

Health Technology

| -6.87% | O: 0.28% H: 0.0% C: -1.32%
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 24.9% | O: 0.08% H: 0.81% C: -0.19%
SNY | News | $46.32 2.05% 2.01% 3.3M |

Health Technology

| -6.08% | O: 0.52% H: 0.72% C: -0.34%
INCY | $52.3 -0.98% -0.99% 2.2M |

Health Technology

| -16.48% | O: 0.35% H: 1.07% C: -0.27%
candidate tumors collaboration trial advanced china therapy

---

BioMarin Announces Governance Enhancements and Value Creation Initiatives
Published: 2023-12-20 (Crawled : 21:00) - prnewswire.com
LLY | News | $726.31 -2.63% -0.04% 3.5M |

Health Technology

| 27.38% | O: 0.21% H: 0.63% C: 0.1%
XRAY A | $30.5 0.2% 0.2% 1.8M |

Health Technology

| -10.35% | O: 1.15% H: 2.32% C: 2.27%
BMRN | $88.68 -1.54% -1.57% 1.8M |

Health Technology

| -4.35% | O: 1.44% H: 2.43% C: 1.24%

---

Gainers vs Losers

67%

33%

Top 10 Gainers

AGBA | News | $1.26 215.0% 68.25% 130M |

Finance

EGOX | $0.0515 43.06% 30.1% 330M |

OLB 4 | $0.33 -14.95% 25.53% 840K |

Technology Services

NVFY | $2.77 31.28% 23.83% 33M |

Consumer Durables

ZCMD | $1.87 28.97% 22.46% 31M |

Commercial Services

RCON | $0.1112 13.01% 21.28% 1.7M |

Distribution Services

INSG | $3.03 25.21% 20.13% 330K |

Electronic Technology

GCTK | $0.8191 22.25% 18.2% 190K |

Manufacturing

WLGS | $0.59 18.0% 17.9% 2.3M |

ASNS | $0.828 21.75% 17.86% 18K |

---

Your saved searches

---